CIDRAP newsletters options
A letter yesterday in the New England Journal of Medicine (NEJM) from Centers for Disease Control and Prevention scientists shows homologous (same-vaccine) boosting for Johnson & Johnson (J&J) vaccine recipients was significantly less effective than mix-and-match booster doses when the Omicron strain was predominant in the United States.
Though given to only 1 patient, tecovirimat was tied to a shorter illness and signs of shorter viral shedding.
Two global regions that saw recent increases in infections are now seeing downturns, but the US reports the most new cases and deaths.
Cases in Europe have risen to 118, and the UK has now confirmed 78 monkeypox infections.
UK-based charitable foundation Wellcome is funding and co-developing a new project aimed at helping countries with limited resources make the best use of antimicrobial resistance (AMR) surveillance data to optimize antibiotic use and help reduce the spread of drug-resistant pathogens.
Transmission of COVID-19 was significantly lower, and viable virus was detected for a shorter period, in fully vaccinated patients and staff isolated at a South Korean hospital than in their partially vaccinated and unvaccinated counterparts, finds a study published yesterday in JAMA Network Open.
The agency also alerts clinicians about COVID-19 rebound after Paxlovid.
COVID-19 patients had persistent signs of heart and lung involvement, inflammation, and clotting.
California and Washington state report their first cases, as CDC experts advise on what doctors should be alert for.
Flu levels are up sharply in some Australian states, putting pressure on healthcare systems that are also coping with ongoing COVID-19 activity and prompting more efforts to get more people vaccinated against flu.
A study from Israel published today in BMJ shows that the effectiveness of a fourth dose of Pfizer-BioNTech's mRNA COVID vaccine waned faster than a third dose in adults ages 60 and older.
The CDC says many patients have a distinctive monkeypox rash around their genitals, and UK officials report 36 new infections.
A plant closing could affect 5 essential generic drugs for which Teva had an over 15% market share.
FDA advisers will meet in a few weeks to discuss emergency use of 3 doses.
Compared with Omicron, MIS-C rate was 14 times higher amid Alpha and 13 times higher during Delta.
While COVID-19–related thyroid inflammation usually resolves shortly after the acute illness, about half of participants in a study presented today at the 24th European Congress of Endocrinology still had thyroid abnormalities a year later. The congress is being held May 21 to 24 in Milan, Italy.
The World Health Organization (WHO) last week published its strategic priorities for tackling antimicrobial resistance (AMR).
The document lays out four strategic priority areas that incorporate what the WHO says are the essential components of the AMR response at global, regional, and country levels. It also lists the key achievements and the next steps that need to be taken in those four areas.
A large study shows a 12.8% long COVID decline after the first dose and an 8.8% drop after the second.
At least 8 European countries and Canada, the US, and Australia have tallied cases.
Only 16% of people in low-income countries have received a single COVID vaccine dose.
